Literature DB >> 28500913

MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.

Alex Panaccione1, Yi Zhang1, Molly Ryan2, Christopher A Moskaluk3, Karen S Anderson4, Wendell G Yarbrough5, Sergey V Ivanov6.   

Abstract

Cancer stem cells (CSC) are considered the major cause of aggressive tumor behavior, recurrence, metastases, and resistance to radiation, making them an attractive therapeutic target. However, isolation of CSC from tumor tissue and their characterization are challenging due to uncertainty about their molecular markers and conditions for their propagation. Adenoid cystic carcinoma (ACC), which arises predominantly in the salivary glands, is a slow-growing but relentless tumor that frequently invades nerves and metastasizes. New effective treatment approaches for ACC have not emerged over the last 40years. Previously, based on a highly conserved SOX10 gene signature that we identified in the majority of ACC tumors, we suggested the existence in ACC of SOX10+ cells with neural stem properties and corroborated this hypothesis via isolation from ACC tissue a novel population of CSC, termed ACC-CSC. These cells activated NOTCH1 signaling and co-expressed SOX10 and other ACC-intrinsic neural crest stem cell markers with CD133, a CSC cell surface marker, suggesting that ACC is driven by a previously uncharacterized population of SOX10+/CD133+ cells with neural stem cell properties. Here, we authenticated ACC identity of our primary cultures by demonstrating that most of them harbor MYB-NFIB fusions, which are found in 86% of ACC. We demonstrated using CyTOF, a novel mass cytometry technology, that these cells express high β-catenin and STAT3 levels and are marked by CD24 and CD44. Finally, to streamline development of ACC cell lines, we developed RT-PCR tests for distinguishing mouse and human cells and used immunomagnetic cell sorting to eliminate mouse cells from long-term cell cultures. Overall, this study describes a new population of CSC that activates signaling pathways associated with poor prognosis, validates their ACC identity, and optimizes approaches that can be used for purification of ACC-CSC and generation of cell lines.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28500913      PMCID: PMC5518784          DOI: 10.1016/j.scr.2017.05.002

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  50 in total

1.  Retraction notice to "Nef from SIVmac239 decreases proliferation and migration of adenoid-cystic carcinoma cells and inhibits angiogenesis" [OO 47 (2011) 847–854].

Authors: 
Journal:  Oral Oncol       Date:  2012-01       Impact factor: 5.337

2.  Metastasis-associated genes in oral squamous cell carcinoma and salivary adenoid cystic carcinoma: a differential DNA chip analysis between metastatic and nonmetastatic cell systems.

Authors:  Satoshi Maruyama; Jun Cheng; Manabu Yamazaki; Xiao-jian Zhou; Zhi-yuan Zhang; Rong-gen He; Takashi Saku
Journal:  Cancer Genet Cytogenet       Date:  2010-01-01

Review 3.  Biological functions of natural antisense transcripts.

Authors:  Wojciech Rosikiewicz; Izabela Makałowska
Journal:  Acta Biochim Pol       Date:  2016-10-21       Impact factor: 2.149

4.  Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.

Authors:  Lina Han; Peng Qiu; Zhihong Zeng; Jeffrey L Jorgensen; Duncan H Mak; Jared K Burks; Wendy Schober; Teresa J McQueen; Jorge Cortes; Scott D Tanner; Gail J Roboz; Hagop M Kantarjian; Steven M Kornblau; Monica L Guzman; Michael Andreeff; Marina Konopleva
Journal:  Cytometry A       Date:  2015-01-16       Impact factor: 4.355

5.  Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells.

Authors:  Christopher Dravis; Benjamin T Spike; J Chuck Harrell; Claire Johns; Christy L Trejo; E Michelle Southard-Smith; Charles M Perou; Geoffrey M Wahl
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

6.  Sox10: a pan-schwannian and melanocytic marker.

Authors:  Daisuke Nonaka; Luis Chiriboga; Brian P Rubin
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

7.  Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.

Authors:  Henry F Frierson; Adel K El-Naggar; John B Welsh; Lisa M Sapinoso; Andrew I Su; Jun Cheng; Takashi Saku; Christopher A Moskaluk; Garret M Hampton
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 8.  Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.

Authors:  Gemma Leon; Lauren MacDonagh; Stephen P Finn; Sinead Cuffe; Martin P Barr
Journal:  Pharmacol Ther       Date:  2015-12-17       Impact factor: 12.310

9.  MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.

Authors:  Lijuan Sun; Bodu Liu; Zhaoyu Lin; Yandan Yao; Yanyang Chen; Yang Li; Jianing Chen; Dongsheng Yu; Zhangui Tang; Bosheng Wang; Shuguang Zeng; Song Fan; Youyuan Wang; Yilin Li; Erwei Song; Jinsong Li
Journal:  Mol Cancer       Date:  2015-04-29       Impact factor: 27.401

10.  An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.

Authors:  Yotam Drier; Matthew J Cotton; Kaylyn E Williamson; Shawn M Gillespie; Russell J H Ryan; Michael J Kluk; Christopher D Carey; Scott J Rodig; Lynette M Sholl; Amir H Afrogheh; William C Faquin; Lurdes Queimado; Jun Qi; Michael J Wick; Adel K El-Naggar; James E Bradner; Christopher A Moskaluk; Jon C Aster; Birgit Knoechel; Bradley E Bernstein
Journal:  Nat Genet       Date:  2016-02-01       Impact factor: 38.330

View more
  11 in total

Review 1.  Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors.

Authors:  Akshitkumar M Mistry; Allison R Greenplate; Rebecca A Ihrie; Jonathan M Irish
Journal:  FEBS J       Date:  2019-01-07       Impact factor: 5.542

2.  Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.

Authors:  Joseph O Humtsoe; Hyun-Su Kim; Leilani Jones; James Cevallos; Philippe Boileau; Fengshen Kuo; Luc G T Morris; Patrick Ha
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

3.  Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression.

Authors:  Stephen B Keysar; Justin R Eagles; Bettina Miller; Brian C Jackson; Farshad N Chowdhury; Julie Reisinger; Tugs-Saikhan Chimed; Phuong N Le; John J Morton; Hilary L Somerset; Marileila Varella-Garcia; Aik-Choon Tan; John I Song; Daniel W Bowles; Mary E Reyland; Antonio Jimeno
Journal:  Clin Cancer Res       Date:  2018-03-19       Impact factor: 12.531

4.  Identification of CD24 as a marker for tumorigenesis of melanoma.

Authors:  Ming-Rui Tang; Jia-Yan Guo; Di Wang; Nan Xu
Journal:  Onco Targets Ther       Date:  2018-06-12       Impact factor: 4.147

5.  Isolation of cancer stem cells by selection for miR-302 expressing cells.

Authors:  Karim Rahimi; Annette C Füchtbauer; Fardin Fathi; Seyed J Mowla; Ernst-Martin Füchtbauer
Journal:  PeerJ       Date:  2019-03-26       Impact factor: 2.984

Review 6.  Targeting cancer stem cells in drug discovery: Current state and future perspectives.

Authors:  Fang-Yu Du; Qi-Fan Zhou; Wen-Jiao Sun; Guo-Liang Chen
Journal:  World J Stem Cells       Date:  2019-07-26       Impact factor: 5.326

Review 7.  Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.

Authors:  Xuefeng Liu; Abdul M Mondal
Journal:  J Med Virol       Date:  2020-06-16       Impact factor: 2.327

8.  Effects of CD133 expression on chemotherapy and drug sensitivity of adenoid cystic carcinoma.

Authors:  Lian Zhou; Ying Sun; Guo Ye; Yanguang Zhao; Jian Wu
Journal:  Mol Med Rep       Date:  2021-11-18       Impact factor: 2.952

9.  Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma.

Authors:  Joseph Mandelbaum; Ilya A Shestopalov; Rachel E Henderson; Nicole G Chau; Birgit Knoechel; Michael J Wick; Leonard I Zon
Journal:  J Exp Med       Date:  2018-09-12       Impact factor: 14.307

Review 10.  Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.

Authors:  Nancy Palechor-Ceron; Ewa Krawczyk; Aleksandra Dakic; Vera Simic; Hang Yuan; Jan Blancato; Weisheng Wang; Fleesie Hubbard; Yun-Ling Zheng; Hancai Dan; Scott Strome; Kevin Cullen; Bruce Davidson; John F Deeken; Sujata Choudhury; Peter H Ahn; Seema Agarwal; Xuexun Zhou; Richard Schlegel; Priscilla A Furth; Chong-Xian Pan; Xuefeng Liu
Journal:  Cells       Date:  2019-10-27       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.